// App-Quantinova.ai

: Phase 1 Randomized Placebo-Controlled Study in Healthy Adult Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate – A Potential Treatment for COVID-19

Researchers

Presenter

  • Ohad Bentur

Principal Investigators

  • Richard Hutt

  • Donna Brassil

  • Per Bckman

  • Igor Gonda

  • Homer Boushey

  • B. Cahrous

  • Barry Coller

  • Robert MacArthur

Medical Centers

  • The Rockefeller University, New York, NY

  • Emmace Consulting AB, Lund, Sweden

  • Respidex LLC, Dennis, MA

  • University of California, San Francisco, CA

  • Pulmoquine Therapeutics Inc. CA

  • The Rockefeller University, New York, NY

Locations

  • United States

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Aerosolized hydroxychloroquine (inhalation)

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Pharmacokinetics

  • Controlled

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved